ITI Pharma and Healthcare Fund Regular vs Tata India Pharma & Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹233 Cr | ₹1325 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.35 | 2.14 |
| Manager | Rohan Korde | Meeta Shetty |
| ISIN Code | INF00XX01BL5 | INF277K016A9 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -2.6% | -1.46% |
| 6 Month | -2.51% | 1.52% |
| 1 Year | -7.03% | -0.19% |
| 3 Year | 18.82% | 21.93% |
| 5 Year | - | 15.94% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | -3.25% | -1.22% |
| 1 Year | -1.61% | 4.63% |
| 3 Year | 13.79% | 17.22% |
| 5 Year | - | 16.69% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 18.94% | 8.63% |
| 3 Year | 20.21% | 18.84% |
| 5 Year | - | 15.73% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 15.68% | 16.04% |
| Sharp | 0.75% | 0.91% |
| Beta | 0.95% | 0.98% |
| Alpha | -3.33% | -1.01% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Rohan Korde | Meeta Shetty |
| Total AUM | ₹4626 Cr | ₹17847 Cr |
| Funds Managed | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 3.94 | 3.86 |
| Large Cap | 32.04 | 22.93 |
| Mid Cap | 36.31 | 38.84 |
| Small Cap | 27.72 | 34.36 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.7 | 1.5 |
| Healthcare | 93.14 | 96.33 |
| Basic Materials | 2.87 | 2.17 |
| Industrials | 1.05 | - |
| Financial Services | 1.25 | 0 |
Top Comparisons
LIC MF Gold ETF Fund of Fund -Regular Plan-Growth
3Y Returns32.72%
DSP GOLD ETF FUND OF FUND REGULAR PLAN GROWTH
3Y Returns0%
SBI Focused Fund - Regular Plan -Growth
3Y Returns17.27%
360 ONE Focused Fund Regular-Growth
3Y Returns14.83%
Sundaram Corporate Bond Fund Regular Plan- Growth
3Y Returns7.3%
HSBC Corporate Bond Fund - Regular Growth
3Y Returns7.46%
UTI Liquid Fund - Regular Plan - Growth Option
3Y Returns6.97%
Baroda BNP Paribas LIQUID FUND - Regular Plan - GROWTH OPTION
3Y Returns6.91%